Do GLP-1 meds cause more fat cells?
Spencer Nadolsky, DOPublished on March 19, 2025
Summary authored by editor@wellifi.com
TLDR Summary
In this episode of the Docs Who Lift Podcast, Dr. Spencer Nadolsky and Dr. Carl Nadolsky Jr. debunk myths surrounding ketogenic diets and GLP-1 medications, emphasizing the importance of evidence-based information and the positive impacts of these drugs on weight management and mental health. They encourage critical thinking when consuming health-related information.
Key Points
- Criticism of pseudoscientific claims made by keto advocates.
- Clarification that GLP-1 medications do not significantly increase risks of bone loss or mental health issues.
- Recent studies suggest GLP-1 drugs can improve mood and reduce food preoccupation.
- Importance of relying on human clinical trials over animal studies for health claims.
- Advocacy for strength training as a foundational therapy for maintaining health.
The Docs Who Lift Podcast: Debunking Keto Zealotry and GLP-1 Drug Myths
Welcome to the Docs Who Lift Podcast, a platform dedicated to simplifying the complexities of a healthy lifestyle, exercise medicine, and weight loss. In this episode, hosts Dr. Spencer Nadolsky and Dr. Carl Nadolsky Jr. tackle the misinformation surrounding ketogenic diets and GLP-1 medications, particularly focusing on the fear-mongering claims made by certain individuals in the health community.
Keto Zealotry and Misinformation
Dr. Spencer Nadolsky opens the discussion by criticizing the work of a self-proclaimed scientist and keto enthusiast, Ben Bman, who propagates pseudoscientific information regarding ketogenic diets and GLP-1 drugs. While acknowledging that some keto researchers provide valuable insights, he emphasizes the importance of distinguishing between credible science and exaggerated claims.
Understanding GLP-1 Drugs
Dr. Nadolsky outlines the benefits of GLP-1 medications, which have been approved for the treatment of type 2 diabetes and weight management. He addresses the misconceptions about these drugs leading to bone loss and mental health issues, clarifying that recent studies show no significant risk of these side effects. Instead, many patients experience improvements in mood as they no longer obsess over food.
Debunking the Myths
- Ben Bman's claims about GLP-1 medications causing osteoporotic changes and lean mass loss are unfounded and misleading.
- There is no evidence suggesting that these medications lead to increased suicidal ideation or mental health crises.
- Studies indicate that GLP-1 drugs generally improve mood due to reduced food preoccupation.
Fat Cell Dynamics: A Deeper Dive
One of the key points in Bman's argument is that GLP-1 drugs might increase the number of fat cells (hyperplasia) while reducing their size (hypertrophy). The hosts clarify that while some animal studies have shown this phenomenon, it does not translate to negative clinical outcomes in humans. They emphasize the importance of human clinical trials, which demonstrate the drugs' effectiveness in weight management and metabolic health.
Conclusion: The Importance of Science-Based Discussions
Dr. Nadolsky concludes the episode by urging listeners to approach health information critically, especially when it comes from individuals lacking scientific credentials. He advocates for strength training as a foundational therapy for maintaining muscle mass and overall health, regardless of any potential changes in fat cell dynamics.
In a world filled with misinformation, the Docs Who Lift Podcast aims to provide clarity and evidence-based insights into health and wellness topics.